Grey Wolf Animal Health Corp. provides products, solutions, and services for the health and wellness of animals in Canada and internationally. It operates through two segments, the Animal Health Business Unit, and the Pharmacy Business Unit. The company provides products such as pharmaceuticals which includes sedaject, ataject, and thyro-tabs canine; nutraceuticals, which includes Composure Pro, Vertiflex, hide and treat, Entero Aid +Gi, Fibre Boost +Gi, and Hepaticlear Pro; and wound care products, including medical pet shirt protective wear that comprise pet shirt, pets boot, head cover, and leg sleeves; and disposables comprising syringes, needles, and iv catheters. Grey Wolf Animal Health Corp. was founded in 2015 and is headquartered in Toronto, Canada.
Stock data | 2024 | Change |
---|---|---|
Price | $0.653714789378971 | N/A |
Market Cap | $20.29M | N/A |
Shares Outstanding | 31.03M | N/A |
Employees | 0 | N/A |